NDC codes

454321 NDC codes with hospital pricing data in the network.

• NDC 00078-0883-61 — CRIZANLIZUMAB-TMCA 100 MG/10ML IV SOLN (148 hospitals, 1,542–1,605 samples)
• NDC 42023-0214-10 — PHENYLEPHRINE 10 MG/ML INJECTION SOLUTION (52 hospitals, 1,307–1,604 samples)
• NDC 60687073665 — PANTOPRAZOLE SODIUM 40 MG PO TBEC (91 hospitals, 1,027–1,603 samples)
• NDC 63323-265-30 — METHYLPREDNISOLONE SODIUM SUCC 1000 MG IJ SOLR (156 hospitals, 1,432–1,603 samples)
• NDC 338979101 — Sodium Chloride IV Soln 0.9% (37 hospitals, 1,413–1,602 samples)
• NDC 60687-0231-11 — SERTRALINE 25 MG TABLET (111 hospitals, 1,429–1,600 samples)
• NDC 62935-0453-45 — LEUPROLIDE ACETATE 45 MG (6 MONTH) SUBCUTANEOUS SYRINGE (131 hospitals, 1,123–1,600 samples)
• NDC 00015-0580-11 — cholestyramine 4 gm/Sucrose Pkt (11 hospitals, 1,519–1,600 samples)
• NDC 00143-9316-24 — LEVOFLOXACIN 500 MG/100 ML IN 5 % DEXTROSE INTRAVENOUS PIGGYBACK (44 hospitals, 1,600 samples)
• NDC CHCO1-8111-68 — MORPHINE NCA/CCA 1 MG/ML HIGH DOSE LIMIT - NON WEIGHT BASED (1 hospital, 160–1,600 samples)
• NDC CHCO1-8112-44 — MORPHINE PCA 1 MG/ML OPIOID TOLERANT (1 hospital, 160–1,600 samples)
• NDC 69918-0700-10 — SUCCINYLCHOLINE CHLORIDE SOLN 20 MG/ML200 MG (25 hospitals, 1,428–1,599 samples)
• NDC 00407-1414-03 — IOHEXOL 350 MG IODINE/ML IV SOLN 150 ML BTL (11 hospitals, 1,563–1,599 samples)
• NDC 00904-6255-49 — BENZOCAINE-MENTHOL 15-3.6 MG MM LOZG (140 hospitals, 1,373–1,598 samples)
• NDC 60258000615 — POTASSIUM & SODIUM PHOSPHATES 280-160-250 MG OR PACK (242 hospitals, 1,409–1,598 samples)
• NDC 31722-0981-10 — SUCCINYLCHOLINE CHLORIDE 20 MG/ML INJECTION SOLUTI (49 hospitals, 1,443–1,596 samples)
• NDC 00409-1176-30 — DEMEROL 25 ML INJ (164 hospitals, 1,055–1,595 samples)
• NDC 00338-0491-03 — Lipids 20% Inje (7 hospitals, 1,397–1,595 samples)
• NDC 0338007225 — KETOROLAC 30 MG/ML (1 ML) INJECTION SOLUTION (58 hospitals, 362–1,595 samples)
• NDC 0409379501 — KETOROLAC TROMETHAMINE 30 MG/ML IJ SOLN (70 hospitals, 362–1,595 samples)
• NDC 0409379519 — KETOROLAC 30 MG/ML (1 ML) INJECTION SOLUTION (68 hospitals, 362–1,595 samples)
• NDC 0641604201 — KETOROLAC 30 MG/ML (1 ML) INJECTION SOLUTION (43 hospitals, 362–1,595 samples)
• NDC 0641604225 — KETOROLAC 30 MG/ML (1 ML) INJECTION SOLUTION (61 hospitals, 362–1,595 samples)
• NDC 2502170101 — KETOROLAC 30 MG/ML (1 ML) INJECTION SOLUTION (43 hospitals, 362–1,595 samples)
• NDC 6233260001 — KETOROLAC 30 MG/ML (1 ML) INJECTION SOLUTION (43 hospitals, 362–1,595 samples)
• NDC 6233260025 — KETOROLAC 30 MG/ML SOLN (44 hospitals, 362–1,595 samples)
• NDC 6332316201 — KETOROLAC 30 MG/ML INJECTION SOLUTION (SO) (80 hospitals, 362–1,595 samples)
• NDC 7086070103 — KETOROLAC 30 MG/ML (1 ML) INJECTION SOLUTION (52 hospitals, 362–1,595 samples)
• NDC 7086070141 — KETOROLAC 30 MG/ML (1 ML) INJECTION SOLUTION (46 hospitals, 362–1,595 samples)
• NDC 7226611801 — KETOROLAC TROMETHAMINE 30 MG/ML IJ SOLN (63 hospitals, 362–1,595 samples)
• NDC 7226611825 — KETOROLAC 30 MG/ML (1 ML) INJECTION SOLUTION (77 hospitals, 362–1,595 samples)
• NDC 59385002460 — BELBUCA 450 MCG BUCCAL FILM (143 hospitals, 1,352–1,595 samples)
• NDC 00085-0566-05 — INJECTION, BETAMETHASONE ACETATE 3 MG AND BETAMETHASONE SODIUM PHOSPHATE 3 MG (48 hospitals, 1,053–1,593 samples)
• NDC 00009347503 — DEPO-MedroL (158 hospitals, 297–1,593 samples)
• NDC 58160082311 — SHINGRIX SDV 50MCG 0.5ML (199 hospitals, 1,026–1,593 samples)
• NDC 68462058440 — NDC Description Not Available (46 hospitals, 1,161–1,593 samples)
• NDC 00409-6625-30 — SODIUM BICARBONATE 1 MEQ/ML (8.4 %) INTRAVENOUS SOLUTION (39 hospitals, 1,473–1,590 samples)
• NDC 99998-0062-05 — IBUPROFEN 100 MG/5 ML ORAL SUSPENSION (1 hospital, 1,590 samples)
• NDC 00409-0125-01 — CEFEPIME IN SWFI/NS 2 G/20 ML INJECTION (61 hospitals, 950–1,589 samples)
• NDC 641614610 — Dexamethasone Sodium Phosphate Inj 4 MG/ML,Dexamethasone Sodium Phosphate Inj 20 MG/5ML,Dexamethasone Sodium Phosphate Inj 120 MG/30ML,Dexamethasone Sodium Phosphate Inj Soln Pref Syr 4 MG/ML (66 hospitals, 1,382–1,589 samples)
• NDC 44567070810 — ceFAZolin (133 hospitals, 391–1,588 samples)
• NDC 76329-1912-01 — MORPHINE 1 MG/ML PCA IV SOLN OPIOID NAIVE - 4 HR DOSE LIMIT (WRAPPER) (155 hospitals, 1,182–1,587 samples)
• NDC 00409-6629-12 — SUCCINYLCHOLINE CHLORIDE 20 MG/ML INJECTION SOLUTION (40 hospitals, 1,442–1,586 samples)
• NDC 10019-0957-01 — CYCLOPHOSPHAMIDE 2 GRAM INTRAVENOUS POWDER FOR SOLUTION (73 hospitals, 1,523–1,586 samples)
• NDC 14789-0104-07 — SUCCINYLCHOLINE CHLORIDE 20 MG/ML INJECTION **DH WRAPPED** (13 hospitals, 1,442–1,586 samples)
• NDC 70121-1581-01 — SUCCINYLCHOLINE CHLORIDE 20 MG/ML INJECTION SOLUTION (32 hospitals, 1,442–1,586 samples)
• NDC 54879-0037-25 — SUCCINYLCHOLINE CHLORIDE 20 MG/ML INJECTION SOLUTION (12 hospitals, 1,442–1,586 samples)
• NDC 51991-0964-99 — Succinylcholine Inj 20 mg/mL 10 mL (UD) (20 hospitals, 1,442–1,586 samples)
• NDC 00009082501 — HYDROCORTISONE SOD SUC (PF) 100 MG IJ SOLR (245 hospitals, 271–1,585 samples)
• NDC 00054458111 — MERCAPTOPURINE 50 MG TABLET (237 hospitals, 1,396–1,585 samples)